Search results
Nicotine-like chemicals in US vapes may be more potent than nicotine, FDA says - BusinessWorld...
BusinessWorld· 1 day agoNicotine alternatives used in vapes being launched in the US and abroad, such as 6-methyl nicotine,...
Baby formula recall as "noncompliance" warning issued
Newsweek· 6 days agoA Texas-based company is recalling baby formula products after they were found to be in...
Baby formula recalled after company fails to meet FDA regulations
AOL· 2 days agoCans of baby formula sold under the brand names Crecelac and Farmalac have been recalled because the...
Ozempic and weight loss drug shortages can now be tracked by patients
Quartz· 2 days agoSeveral doses of Wegovy, Zepbound, and Mounjaro are all currently in limited supply due to increased...
Nationwide water recall update as FDA issues level of concern
Newsweek· 4 days agoThe U.S. Food and Drug Administration (FDA) has issued an update regarding a previous recall for...
FDA approves higher dose of Catalyst's LEMS drug By Investing.com
Investing.com· 1 day agoCatalyst Pharmaceuticals, Inc. (NASDAQ: CPRX), a commercial-stage biopharmaceutical company,...
Exclusive-Nicotine-like chemicals in U.S. vapes may be more potent than nicotine, FDA says
Reuters via AOL· 2 days agoand abroad, such as 6-methyl nicotine, may be more potent and addictive than nicotine itself, though...
Family of woman who died after eating cookie not labeled as containing peanuts sues grocery chain
Scripps News via AOL· 2 days agoFood Investigators are working hard with the Department of Public Health, local health departments,...
JBS says China blocks beef from US plant over detection of ractopamine
Reuters via AOL· 2 days agoBrazil-based JBS, the world's largest beef producer, said in a statement it is working with U.S. and...
Moderna Receives U.S. FDA Approval for RSV Vaccine mRESVIA(R)
Digital Journal· 6 hours agomRESVIA is Moderna's second approved product and the only RSV vaccine available in single-dose pre-filled syringes CAMBRIDGE, MA / ACCESSWIRE / May 31, 2024 / Moderna, Inc ...